NLRP3 and Anxiety: Our in vivo study clearly demonstrated that Tojapride effectively ameliorated modified RE rat anxiety‐related behaviour, prevented reflux of gastric and duodenal contents, diminished the pathological impairment and inhibited the proinflammatory pathway of the CaSR/NLRP3 inflammasome.